Literature DB >> 27453783

Materials design at the interface of nanoparticles and innate immunity.

Gregory Lee Szeto1, Erin B Lavik1.   

Abstract

Entities:  

Year:  2016        PMID： 27453783      PMCID： PMC4950994          DOI： 10.1039/C5TB01825K

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN： 2050-750X            Impact factor:   6.331


× No keyword cloud information.
  91 in total

1.  Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412.

Authors:  Paula S Römer; Susanne Berr; Elita Avota; Shin-Young Na; Manuela Battaglia; Ineke ten Berge; Hermann Einsele; Thomas Hünig
Journal:  Blood       Date:  2011-09-19       Impact factor: 22.113

2.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Authors:  Seung-Yong Seong; Polly Matzinger
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

3.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

4.  The influence of size and charge of chitosan/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility.

Authors:  Biraja C Dash; Gildas Réthoré; Michael Monaghan; Kathleen Fitzgerald; William Gallagher; Abhay Pandit
Journal:  Biomaterials       Date:  2010-08-10       Impact factor: 12.479

5.  Signaling pathways initiated in macrophages after engagement of type A scavenger receptors.

Authors:  S P Coller; D M Paulnock
Journal:  J Leukoc Biol       Date:  2001-07       Impact factor: 4.962

6.  Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children.

Authors:  Xiao-Jun Xu; Yong-Min Tang; Hua Song; Shi-Long Yang; Wei-Qun Xu; Ning Zhao; Shu-Wen Shi; He-Ping Shen; Jun-Qing Mao; Ling-Yan Zhang; Bin-Hua Pan
Journal:  J Pediatr       Date:  2012-01-09       Impact factor: 4.406

Review 7.  Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.

Authors:  Janos Szebeni; Franco Muggia; Alberto Gabizon; Yechezkel Barenholz
Journal:  Adv Drug Deliv Rev       Date:  2011-07-14       Impact factor: 15.470

8.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions.

Authors:  Alessandro Parodi; Nicoletta Quattrocchi; Anne L van de Ven; Ciro Chiappini; Michael Evangelopoulos; Jonathan O Martinez; Brandon S Brown; Sm Z Khaled; Iman K Yazdi; Maria Vittoria Enzo; Lucas Isenhart; Mauro Ferrari; Ennio Tasciotti
Journal:  Nat Nanotechnol       Date:  2012-12-16       Impact factor: 39.213

Review 9.  Molecular mechanisms of endotoxin tolerance.

Authors:  Hongkuan Fan; James A Cook
Journal:  J Endotoxin Res       Date:  2004

10.  Size-dependent cytotoxicity of gold nanoparticles.

Authors:  Yu Pan; Sabine Neuss; Annika Leifert; Monika Fischler; Fei Wen; Ulrich Simon; Günter Schmid; Wolfgang Brandau; Willi Jahnen-Dechent
Journal:  Small       Date:  2007-11       Impact factor: 13.281
View more
  11 in total

1.  Assessment of Complement Activation by Nanoparticles: Development of a SPR Based Method and Comparison with Current High Throughput Methods.

Authors:  Jean-Baptiste Coty; Magali Noiray; Christine Vauthier
Journal:  Pharm Res       Date:  2018-04-26       Impact factor: 4.200

Review 2.  Effects of engineered nanoparticles on the innate immune system.

Authors:  Yuanchang Liu; Joseph Hardie; Xianzhi Zhang; Vincent M Rotello
Journal:  Semin Immunol       Date:  2017-10-04       Impact factor: 11.130

3.  Development of a Sensitive Assay to Screen Nanoparticles in vitro for Complement Activation.

Authors:  Nuzhat Maisha; Tobias Coombs; Erin Lavik
Journal:  ACS Biomater Sci Eng       Date:  2020-07-06

Review 4.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

Review 5.  Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery.

Authors:  Xinyi Ma; Qingxiang Song; Xiaoling Gao
Journal:  Acta Pharm Sin B       Date:  2017-12-24       Impact factor: 11.413

Review 6.  Nanoparticle-Based Vaccines Against Respiratory Viruses.

Authors:  Soultan Al-Halifa; Laurie Gauthier; Dominic Arpin; Steve Bourgault; Denis Archambault
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

7.  Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.

Authors:  Sanne Duinkerken; Sophie K Horrevorts; Hakan Kalay; Martino Ambrosini; Lisa Rutte; Tanja D de Gruijl; Juan J Garcia-Vallejo; Yvette van Kooyk
Journal:  Theranostics       Date:  2019-08-12       Impact factor: 11.556

8.  Sea Urchin Extracellular Proteins Design a Complex Protein Corona on Titanium Dioxide Nanoparticle Surface Influencing Immune Cell Behavior.

Authors:  Andi Alijagic; Oldřich Benada; Olga Kofroňová; Diego Cigna; Annalisa Pinsino
Journal:  Front Immunol       Date:  2019-09-20       Impact factor: 7.561

Review 9.  Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine.

Authors:  Ninh M La-Beck; Md Rakibul Islam; Maciej M Markiewski
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

Review 10.  Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy.

Authors:  Sangram Raut; Linda Mooberry; Nirupama Sabnis; Ashwini Garud; Akpedje Serena Dossou; Andras Lacko
Journal:  Front Pharmacol       Date:  2018-10-15       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.